Table 3.
| Cancer tissue | Type of a cancer or cancer cell line | Expression of KV1.3 | Contradictory data |
|---|---|---|---|
| Colon | Colon adenocarcinoma | Altered | |
| Breast | Highly tumorigenic M13SV1R2‐N1, weakly tumorigenic M13SV1R2 cells | Elevateda | Abdul et al.: protein levels vary 45 |
| Grade I and II breast adenocarcinoma | Elevateda | ||
| Grade III breast adenocarcinoma | Decreaseda | ||
| Prostate | Weakly metastatic LNCaP, AT‐2 | Elevateda | In PC3, DU145, LNCaP, MDA‐PCA‐2B cell lines 46 |
| Strongly metastatic PC3 and Mat‐LyLu | Decreaseda | ||
| Benign prostatic hyperplasia, human prostate cancer | Elevated | ||
| Smooth muscle | Leiomyoma | Decreased | |
| Leiomyosarcoma | Elevated | ||
| Skeletal muscle | Embryonal rabdomyosarcoma | Decreased | |
| Alveolar rabdomyosarcoma | Elevated | ||
| Brain | Astrocytoma | Decreased | |
| Oligodendroglioma | Decreased | ||
| Glioblastoma | Decreased | ||
| Lymph node | Follicular B‐cell lymphoma | Decreased | |
| Mantle lymphoma | Decreased | ||
| T‐cell lymphoma | Decreased | ||
| Diffuse large B‐cell lymphoma | Altered | ||
| Anaplastic lymphoma | Decreased | ||
| Chronic lymphocytic leukemia | Increased |
a
Expression is compared to healthy and control samples.